363 related articles for article (PubMed ID: 26345641)
1. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia correlates with systemic inflammation in COPD.
Byun MK; Cho EN; Chang J; Ahn CM; Kim HJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():669-675. PubMed ID: 28255238
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
Kharbanda S; Ramakrishna A; Krishnan S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
[TBL] [Abstract][Full Text] [Related]
4. Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
Pleguezuelos E; Esquinas C; Moreno E; Guirao L; Ortiz J; Garcia-Alsina J; Merí A; Miravitlles M
Lung; 2016 Apr; 194(2):249-57. PubMed ID: 26743191
[TBL] [Abstract][Full Text] [Related]
5. Is dynamometry able to infer the risk of muscle mass loss in patients with COPD?
Ramos D; Bertolini GN; Leite MR; Carvalho Junior LC; da Silva Pestana PR; dos Santos VR; Fortaleza AC; Rodrigues FM; Ramos EM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1403-7. PubMed ID: 26229459
[TBL] [Abstract][Full Text] [Related]
6. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.
Yende S; Waterer GW; Tolley EA; Newman AB; Bauer DC; Taaffe DR; Jensen R; Crapo R; Rubin S; Nevitt M; Simonsick EM; Satterfield S; Harris T; Kritchevsky SB
Thorax; 2006 Jan; 61(1):10-6. PubMed ID: 16284220
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
10. Relation between upper-limb muscle strength with exercise capacity, quality of life and dyspnea in patients with severe chronic obstructive pulmonary disease.
Kaymaz D; Candemir İÇ; Ergün P; Demir N; Taşdemir F; Demir P
Clin Respir J; 2018 Mar; 12(3):1257-1263. PubMed ID: 28618190
[TBL] [Abstract][Full Text] [Related]
11. Relation between physical capacity, nutritional status and systemic inflammation in COPD.
Hallin R; Janson C; Arnardottir RH; Olsson R; Emtner M; Branth S; Boman G; Slinde F
Clin Respir J; 2011 Jul; 5(3):136-42. PubMed ID: 21679348
[TBL] [Abstract][Full Text] [Related]
12. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
[TBL] [Abstract][Full Text] [Related]
13. Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women.
Dutra MT; Avelar BP; Souza VC; Bottaro M; Oliveira RJ; Nóbrega OT; Moreno Lima R
Clin Physiol Funct Imaging; 2017 Mar; 37(2):205-210. PubMed ID: 26373437
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
16. Grip strength and inflammatory biomarker profiles in very old adults.
Granic A; Davies K; Martin-Ruiz C; Jagger C; Kirkwood TBL; von Zglinicki T; Aihie Sayer A
Age Ageing; 2017 Nov; 46(6):976-982. PubMed ID: 28541423
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of isokinetic muscle strength of upper limb and the relationship with pulmonary function and respiratory muscle strength in stable COPD patients.
Liu X; Li P; Wang Z; Lu Y; Li N; Xiao L; Duan H; Wang Z; Li J; Shan C; Wu W
Int J Chron Obstruct Pulmon Dis; 2019; 14():2027-2036. PubMed ID: 31564850
[TBL] [Abstract][Full Text] [Related]
18. Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
Barker BL; McKenna S; Mistry V; Pancholi M; Patel H; Haldar K; Barer MR; Pavord ID; Steiner MC; Brightling CE; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2014; 9():975-81. PubMed ID: 25246784
[TBL] [Abstract][Full Text] [Related]
19. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
